Medical Care
Global Laboratory-developed Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307130
- Pages: 141
- Figures: 143
- Views: 3
In 2024, the global market size of Laboratory-developed Testing was estimated to be worth US$ 3789 million and is forecast to reach approximately US$ 4901 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.
North America is the largest market with more than 65% of the market, followed by Europe with about 15%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Laboratory-developed Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Laboratory-developed Testing.
The Laboratory-developed Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Laboratory-developed Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Laboratory-developed Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Adaptive Biotechnologies Corporation
Quest Diagnostics
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Biotheranostics
Adaptive Biotechnologies
Rosetta Genomics
Biodesix
Helix
Segment by Type
Commercial Service
R&D
Segment by Application
Genetic Testing
Oncology
Infectious Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Laboratory-developed Testing in global and regional level.
Chapter 3: Detailed analysis of Laboratory-developed Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Laboratory-developed Testing revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.
North America is the largest market with more than 65% of the market, followed by Europe with about 15%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Laboratory-developed Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Laboratory-developed Testing.
The Laboratory-developed Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Laboratory-developed Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Laboratory-developed Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Adaptive Biotechnologies Corporation
Quest Diagnostics
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Biotheranostics
Adaptive Biotechnologies
Rosetta Genomics
Biodesix
Helix
Segment by Type
Commercial Service
R&D
Segment by Application
Genetic Testing
Oncology
Infectious Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Laboratory-developed Testing in global and regional level.
Chapter 3: Detailed analysis of Laboratory-developed Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Laboratory-developed Testing revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Laboratory-developed Testing Product Introduction
1.2 Market by Type
1.2.1 Global Laboratory-developed Testing Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Commercial Service
1.2.3 R&D
1.3 Market by Application
1.3.1 Global Laboratory-developed Testing Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Genetic Testing
1.3.3 Oncology
1.3.4 Infectious Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Laboratory-developed Testing Market Size Estimates and Forecasts
2.2 Laboratory-developed Testing Market Size by Region: 2024 Versus 2031
2.2.1 Global Laboratory-developed Testing Revenue by Region: 2020-2025
2.2.2 Global Laboratory-developed Testing Revenue Forecast by Region (2026-2031)
2.2.3 Global Laboratory-developed Testing Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Laboratory-developed Testing Revenue by Type (2020-2031)
3.1.2 Global Laboratory-developed Testing Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Laboratory-developed Testing Revenue by Application (2020-2031)
3.2.2 Global Laboratory-developed Testing Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Commercial Service of Laboratory-developed Testing Revenue Market Share by Application
3.3.2 R&D of Laboratory-developed Testing Revenue Market Share by Application
4 Global Laboratory-developed Testing by Company
4.1 Global Laboratory-developed Testing Revenue by Company (2020-2025)
4.2 Global Laboratory-developed Testing Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Laboratory-developed Testing Companies around the World: Ranking by Revenue
4.3.2 Global Laboratory-developed Testing Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Laboratory-developed Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Laboratory-developed Testing Companies Headquarters & Product Type
4.4.1 Global Laboratory-developed Testing Companies Headquarters
4.4.2 Date of International Companies Enter into Laboratory-developed Testing Market
4.4.3 Global Laboratory-developed Testing Companies Product & Service
4.4.4 Commercial Service Revenue Market Share of Laboratory-developed Testing by Company
4.4.5 R&D Revenue Market Share of Laboratory-developed Testing by Company
4.5 Global Laboratory-developed Testing Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Adaptive Biotechnologies Corporation
5.1.1 Adaptive Biotechnologies Corporation Corporation Information
5.1.2 Adaptive Biotechnologies Corporation Description, Business Overview
5.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Products Offered
5.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.1.5 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Product in 2024
5.1.6 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Application in 2024
5.1.7 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Geographic Area in 2024
5.1.8 Adaptive Biotechnologies Corporation Recent Developments
5.2 Quest Diagnostics
5.2.1 Quest Diagnostics Corporation Information
5.2.2 Quest Diagnostics Description, Business Overview
5.2.3 Quest Diagnostics Laboratory-developed Testing Products Offered
5.2.4 Quest Diagnostics Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.2.5 Quest Diagnostics Laboratory-developed Testing Revenue by Product in 2024
5.2.6 Quest Diagnostics Laboratory-developed Testing Revenue by Application in 2024
5.2.7 Quest Diagnostics Laboratory-developed Testing Revenue by Geographic Area in 2024
5.2.8 Quest Diagnostics Recent Developments
5.3 Roche
5.3.1 Roche Corporation Information
5.3.2 Roche Description, Business Overview
5.3.3 Roche Laboratory-developed Testing Products Offered
5.3.4 Roche Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.3.5 Roche Laboratory-developed Testing Revenue by Product in 2024
5.3.6 Roche Laboratory-developed Testing Revenue by Application in 2024
5.3.7 Roche Laboratory-developed Testing Revenue by Geographic Area in 2024
5.3.8 Roche Recent Developments
5.4 Illumina
5.4.1 Illumina Corporation Information
5.4.2 Illumina Description, Business Overview
5.4.3 Illumina Laboratory-developed Testing Products Offered
5.4.4 Illumina Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.4.5 Illumina Laboratory-developed Testing Revenue by Product in 2024
5.4.6 Illumina Laboratory-developed Testing Revenue by Application in 2024
5.4.7 Illumina Laboratory-developed Testing Revenue by Geographic Area in 2024
5.4.8 Illumina Recent Developments
5.5 Qiagen
5.5.1 Qiagen Corporation Information
5.5.2 Qiagen Description, Business Overview
5.5.3 Qiagen Laboratory-developed Testing Products Offered
5.5.4 Qiagen Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.5.5 Qiagen Laboratory-developed Testing Revenue by Product in 2024
5.5.6 Qiagen Laboratory-developed Testing Revenue by Application in 2024
5.5.7 Qiagen Laboratory-developed Testing Revenue by Geographic Area in 2024
5.5.8 Qiagen Recent Developments
5.6 Eurofins
5.6.1 Eurofins Corporation Information
5.6.2 Eurofins Description, Business Overview
5.6.3 Eurofins Laboratory-developed Testing Products Offered
5.6.4 Eurofins Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.6.5 Eurofins Laboratory-developed Testing Revenue by Product in 2024
5.6.6 Eurofins Laboratory-developed Testing Revenue by Application in 2024
5.6.7 Eurofins Laboratory-developed Testing Revenue by Geographic Area in 2024
5.6.8 Eurofins Recent Developments
5.7 Guardant Health
5.7.1 Guardant Health Corporation Information
5.7.2 Guardant Health Description, Business Overview
5.7.3 Guardant Health Laboratory-developed Testing Products Offered
5.7.4 Guardant Health Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.7.5 Guardant Health Laboratory-developed Testing Revenue by Product in 2024
5.7.6 Guardant Health Laboratory-developed Testing Revenue by Application in 2024
5.7.7 Guardant Health Laboratory-developed Testing Revenue by Geographic Area in 2024
5.7.8 Guardant Health Recent Developments
5.8 Biotheranostics
5.8.1 Biotheranostics Corporation Information
5.8.2 Biotheranostics Description, Business Overview
5.8.3 Biotheranostics Laboratory-developed Testing Products Offered
5.8.4 Biotheranostics Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.8.5 Biotheranostics Laboratory-developed Testing Revenue by Product in 2024
5.8.6 Biotheranostics Laboratory-developed Testing Revenue by Application in 2024
5.8.7 Biotheranostics Laboratory-developed Testing Revenue by Geographic Area in 2024
5.8.8 Biotheranostics Recent Developments
5.9 Adaptive Biotechnologies
5.9.1 Adaptive Biotechnologies Corporation Information
5.9.2 Adaptive Biotechnologies Description, Business Overview
5.9.3 Adaptive Biotechnologies Laboratory-developed Testing Products Offered
5.9.4 Adaptive Biotechnologies Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.9.5 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Product in 2024
5.9.6 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Application in 2024
5.9.7 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Geographic Area in 2024
5.9.8 Adaptive Biotechnologies Recent Developments
5.10 Rosetta Genomics
5.10.1 Rosetta Genomics Corporation Information
5.10.2 Rosetta Genomics Description, Business Overview
5.10.3 Rosetta Genomics Laboratory-developed Testing Products Offered
5.10.4 Rosetta Genomics Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.10.5 Rosetta Genomics Laboratory-developed Testing Revenue by Product in 2024
5.10.6 Rosetta Genomics Laboratory-developed Testing Revenue by Application in 2024
5.10.7 Rosetta Genomics Laboratory-developed Testing Revenue by Geographic Area in 2024
5.10.8 Rosetta Genomics Recent Developments
5.11 Biodesix
5.11.1 Biodesix Corporation Information
5.11.2 Biodesix Description, Business Overview
5.11.3 Biodesix Laboratory-developed Testing Products Offered
5.11.4 Biodesix Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.11.5 Biodesix Laboratory-developed Testing Revenue by Product in 2024
5.11.6 Biodesix Laboratory-developed Testing Revenue by Application in 2024
5.11.7 Biodesix Laboratory-developed Testing Revenue by Geographic Area in 2024
5.11.8 Biodesix Recent Developments
5.12 Helix
5.12.1 Helix Corporation Information
5.12.2 Helix Description, Business Overview
5.12.3 Helix Laboratory-developed Testing Products Offered
5.12.4 Helix Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.12.5 Helix Laboratory-developed Testing Revenue by Product in 2024
5.12.6 Helix Laboratory-developed Testing Revenue by Application in 2024
5.12.7 Helix Laboratory-developed Testing Revenue by Geographic Area in 2024
5.12.8 Helix Recent Developments
6 North America
6.1 North America Laboratory-developed Testing Market Size YoY Growth 2020-2031
6.2 North America Laboratory-developed Testing Market Facts & Figures by Country (2020-2031)
6.3 North America Laboratory-developed Testing Revenue by Type (2020-2025)
6.4 North America Laboratory-developed Testing Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Laboratory-developed Testing Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Laboratory-developed Testing Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Laboratory-developed Testing Revenue by Type (2020-2025)
7.4 Asia-Pacific Laboratory-developed Testing Revenue by Application (2020-2025)
8 Europe
8.1 Europe Laboratory-developed Testing Market Size YoY Growth 2020-2031
8.2 Europe Laboratory-developed Testing Market Facts & Figures by Country (2020-2031)
8.3 Europe Laboratory-developed Testing Revenue by Type (2020-2025)
8.4 Europe Laboratory-developed Testing Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Laboratory-developed Testing Market Size YoY Growth 2020-2031
9.2 Latin America Laboratory-developed Testing Market Facts & Figures by Country (2020-2031)
9.3 Latin America Laboratory-developed Testing Revenue by Type (2020-2025)
9.4 Latin America Laboratory-developed Testing Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Laboratory-developed Testing Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Laboratory-developed Testing Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Laboratory-developed Testing Revenue by Type (2020-2025)
10.4 Middle East and Africa Laboratory-developed Testing Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Laboratory-developed Testing Supply Chain Analysis
11.2 Laboratory-developed Testing Key Raw Materials and Upstream Suppliers
11.3 Laboratory-developed Testing Clients Analysis
11.4 Laboratory-developed Testing Sales Channel and Sales Model Analysis
11.4.1 Laboratory-developed Testing Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Laboratory-developed Testing Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Laboratory-developed Testing Distributors
12 Laboratory-developed Testing Market Dynamics
12.1 Laboratory-developed Testing Industry Trends
12.2 Laboratory-developed Testing Market Drivers
12.3 Laboratory-developed Testing Market Challenges
12.4 Laboratory-developed Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Laboratory-developed Testing Product Introduction
1.2 Market by Type
1.2.1 Global Laboratory-developed Testing Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Commercial Service
1.2.3 R&D
1.3 Market by Application
1.3.1 Global Laboratory-developed Testing Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Genetic Testing
1.3.3 Oncology
1.3.4 Infectious Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Laboratory-developed Testing Market Size Estimates and Forecasts
2.2 Laboratory-developed Testing Market Size by Region: 2024 Versus 2031
2.2.1 Global Laboratory-developed Testing Revenue by Region: 2020-2025
2.2.2 Global Laboratory-developed Testing Revenue Forecast by Region (2026-2031)
2.2.3 Global Laboratory-developed Testing Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Laboratory-developed Testing Revenue by Type (2020-2031)
3.1.2 Global Laboratory-developed Testing Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Laboratory-developed Testing Revenue by Application (2020-2031)
3.2.2 Global Laboratory-developed Testing Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Commercial Service of Laboratory-developed Testing Revenue Market Share by Application
3.3.2 R&D of Laboratory-developed Testing Revenue Market Share by Application
4 Global Laboratory-developed Testing by Company
4.1 Global Laboratory-developed Testing Revenue by Company (2020-2025)
4.2 Global Laboratory-developed Testing Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Laboratory-developed Testing Companies around the World: Ranking by Revenue
4.3.2 Global Laboratory-developed Testing Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Laboratory-developed Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Laboratory-developed Testing Companies Headquarters & Product Type
4.4.1 Global Laboratory-developed Testing Companies Headquarters
4.4.2 Date of International Companies Enter into Laboratory-developed Testing Market
4.4.3 Global Laboratory-developed Testing Companies Product & Service
4.4.4 Commercial Service Revenue Market Share of Laboratory-developed Testing by Company
4.4.5 R&D Revenue Market Share of Laboratory-developed Testing by Company
4.5 Global Laboratory-developed Testing Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Adaptive Biotechnologies Corporation
5.1.1 Adaptive Biotechnologies Corporation Corporation Information
5.1.2 Adaptive Biotechnologies Corporation Description, Business Overview
5.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Products Offered
5.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.1.5 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Product in 2024
5.1.6 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Application in 2024
5.1.7 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Geographic Area in 2024
5.1.8 Adaptive Biotechnologies Corporation Recent Developments
5.2 Quest Diagnostics
5.2.1 Quest Diagnostics Corporation Information
5.2.2 Quest Diagnostics Description, Business Overview
5.2.3 Quest Diagnostics Laboratory-developed Testing Products Offered
5.2.4 Quest Diagnostics Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.2.5 Quest Diagnostics Laboratory-developed Testing Revenue by Product in 2024
5.2.6 Quest Diagnostics Laboratory-developed Testing Revenue by Application in 2024
5.2.7 Quest Diagnostics Laboratory-developed Testing Revenue by Geographic Area in 2024
5.2.8 Quest Diagnostics Recent Developments
5.3 Roche
5.3.1 Roche Corporation Information
5.3.2 Roche Description, Business Overview
5.3.3 Roche Laboratory-developed Testing Products Offered
5.3.4 Roche Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.3.5 Roche Laboratory-developed Testing Revenue by Product in 2024
5.3.6 Roche Laboratory-developed Testing Revenue by Application in 2024
5.3.7 Roche Laboratory-developed Testing Revenue by Geographic Area in 2024
5.3.8 Roche Recent Developments
5.4 Illumina
5.4.1 Illumina Corporation Information
5.4.2 Illumina Description, Business Overview
5.4.3 Illumina Laboratory-developed Testing Products Offered
5.4.4 Illumina Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.4.5 Illumina Laboratory-developed Testing Revenue by Product in 2024
5.4.6 Illumina Laboratory-developed Testing Revenue by Application in 2024
5.4.7 Illumina Laboratory-developed Testing Revenue by Geographic Area in 2024
5.4.8 Illumina Recent Developments
5.5 Qiagen
5.5.1 Qiagen Corporation Information
5.5.2 Qiagen Description, Business Overview
5.5.3 Qiagen Laboratory-developed Testing Products Offered
5.5.4 Qiagen Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.5.5 Qiagen Laboratory-developed Testing Revenue by Product in 2024
5.5.6 Qiagen Laboratory-developed Testing Revenue by Application in 2024
5.5.7 Qiagen Laboratory-developed Testing Revenue by Geographic Area in 2024
5.5.8 Qiagen Recent Developments
5.6 Eurofins
5.6.1 Eurofins Corporation Information
5.6.2 Eurofins Description, Business Overview
5.6.3 Eurofins Laboratory-developed Testing Products Offered
5.6.4 Eurofins Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.6.5 Eurofins Laboratory-developed Testing Revenue by Product in 2024
5.6.6 Eurofins Laboratory-developed Testing Revenue by Application in 2024
5.6.7 Eurofins Laboratory-developed Testing Revenue by Geographic Area in 2024
5.6.8 Eurofins Recent Developments
5.7 Guardant Health
5.7.1 Guardant Health Corporation Information
5.7.2 Guardant Health Description, Business Overview
5.7.3 Guardant Health Laboratory-developed Testing Products Offered
5.7.4 Guardant Health Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.7.5 Guardant Health Laboratory-developed Testing Revenue by Product in 2024
5.7.6 Guardant Health Laboratory-developed Testing Revenue by Application in 2024
5.7.7 Guardant Health Laboratory-developed Testing Revenue by Geographic Area in 2024
5.7.8 Guardant Health Recent Developments
5.8 Biotheranostics
5.8.1 Biotheranostics Corporation Information
5.8.2 Biotheranostics Description, Business Overview
5.8.3 Biotheranostics Laboratory-developed Testing Products Offered
5.8.4 Biotheranostics Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.8.5 Biotheranostics Laboratory-developed Testing Revenue by Product in 2024
5.8.6 Biotheranostics Laboratory-developed Testing Revenue by Application in 2024
5.8.7 Biotheranostics Laboratory-developed Testing Revenue by Geographic Area in 2024
5.8.8 Biotheranostics Recent Developments
5.9 Adaptive Biotechnologies
5.9.1 Adaptive Biotechnologies Corporation Information
5.9.2 Adaptive Biotechnologies Description, Business Overview
5.9.3 Adaptive Biotechnologies Laboratory-developed Testing Products Offered
5.9.4 Adaptive Biotechnologies Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.9.5 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Product in 2024
5.9.6 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Application in 2024
5.9.7 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Geographic Area in 2024
5.9.8 Adaptive Biotechnologies Recent Developments
5.10 Rosetta Genomics
5.10.1 Rosetta Genomics Corporation Information
5.10.2 Rosetta Genomics Description, Business Overview
5.10.3 Rosetta Genomics Laboratory-developed Testing Products Offered
5.10.4 Rosetta Genomics Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.10.5 Rosetta Genomics Laboratory-developed Testing Revenue by Product in 2024
5.10.6 Rosetta Genomics Laboratory-developed Testing Revenue by Application in 2024
5.10.7 Rosetta Genomics Laboratory-developed Testing Revenue by Geographic Area in 2024
5.10.8 Rosetta Genomics Recent Developments
5.11 Biodesix
5.11.1 Biodesix Corporation Information
5.11.2 Biodesix Description, Business Overview
5.11.3 Biodesix Laboratory-developed Testing Products Offered
5.11.4 Biodesix Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.11.5 Biodesix Laboratory-developed Testing Revenue by Product in 2024
5.11.6 Biodesix Laboratory-developed Testing Revenue by Application in 2024
5.11.7 Biodesix Laboratory-developed Testing Revenue by Geographic Area in 2024
5.11.8 Biodesix Recent Developments
5.12 Helix
5.12.1 Helix Corporation Information
5.12.2 Helix Description, Business Overview
5.12.3 Helix Laboratory-developed Testing Products Offered
5.12.4 Helix Laboratory-developed Testing Revenue and Gross Margin (2020-2025)
5.12.5 Helix Laboratory-developed Testing Revenue by Product in 2024
5.12.6 Helix Laboratory-developed Testing Revenue by Application in 2024
5.12.7 Helix Laboratory-developed Testing Revenue by Geographic Area in 2024
5.12.8 Helix Recent Developments
6 North America
6.1 North America Laboratory-developed Testing Market Size YoY Growth 2020-2031
6.2 North America Laboratory-developed Testing Market Facts & Figures by Country (2020-2031)
6.3 North America Laboratory-developed Testing Revenue by Type (2020-2025)
6.4 North America Laboratory-developed Testing Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Laboratory-developed Testing Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Laboratory-developed Testing Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Laboratory-developed Testing Revenue by Type (2020-2025)
7.4 Asia-Pacific Laboratory-developed Testing Revenue by Application (2020-2025)
8 Europe
8.1 Europe Laboratory-developed Testing Market Size YoY Growth 2020-2031
8.2 Europe Laboratory-developed Testing Market Facts & Figures by Country (2020-2031)
8.3 Europe Laboratory-developed Testing Revenue by Type (2020-2025)
8.4 Europe Laboratory-developed Testing Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Laboratory-developed Testing Market Size YoY Growth 2020-2031
9.2 Latin America Laboratory-developed Testing Market Facts & Figures by Country (2020-2031)
9.3 Latin America Laboratory-developed Testing Revenue by Type (2020-2025)
9.4 Latin America Laboratory-developed Testing Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Laboratory-developed Testing Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Laboratory-developed Testing Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Laboratory-developed Testing Revenue by Type (2020-2025)
10.4 Middle East and Africa Laboratory-developed Testing Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Laboratory-developed Testing Supply Chain Analysis
11.2 Laboratory-developed Testing Key Raw Materials and Upstream Suppliers
11.3 Laboratory-developed Testing Clients Analysis
11.4 Laboratory-developed Testing Sales Channel and Sales Model Analysis
11.4.1 Laboratory-developed Testing Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Laboratory-developed Testing Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Laboratory-developed Testing Distributors
12 Laboratory-developed Testing Market Dynamics
12.1 Laboratory-developed Testing Industry Trends
12.2 Laboratory-developed Testing Market Drivers
12.3 Laboratory-developed Testing Market Challenges
12.4 Laboratory-developed Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Laboratory-developed Testing Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Laboratory-developed Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Laboratory-developed Testing Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Laboratory-developed Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Laboratory-developed Testing Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Laboratory-developed Testing Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Laboratory-developed Testing Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Laboratory-developed Testing Revenue by Company (2020-2025) & (US$ Million)
Table 11. Laboratory-developed Testing Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Laboratory-developed Testing Players by Revenue (US$ Million) in 2024
Table 13. Global Laboratory-developed Testing Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Laboratory-developed Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Laboratory-developed Testing as of 2024)
Table 15. Global Laboratory-developed Testing Companies Headquarters
Table 16. Date of International Companies Enter into Laboratory-developed Testing Market
Table 17. Global Laboratory-developed Testing Companies Product & Service
Table 18. Global Laboratory-developed Testing Mergers & Acquisitions, Expansion Plans
Table 19. Adaptive Biotechnologies Corporation Corporation Information
Table 20. Adaptive Biotechnologies Corporation Description and Business Overview
Table 21. Adaptive Biotechnologies Corporation Laboratory-developed Testing Product
Table 22. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Adaptive Biotechnologies Corporation Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 24. Adaptive Biotechnologies Corporation Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 25. Adaptive Biotechnologies Corporation Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 26. Adaptive Biotechnologies Corporation Recent Developments
Table 27. Quest Diagnostics Corporation Information
Table 28. Quest Diagnostics Description and Business Overview
Table 29. Quest Diagnostics Laboratory-developed Testing Product
Table 30. Quest Diagnostics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Quest Diagnostics Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 32. Quest Diagnostics Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 33. Quest Diagnostics Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 34. Quest Diagnostics Recent Developments
Table 35. Roche Corporation Information
Table 36. Roche Description and Business Overview
Table 37. Roche Laboratory-developed Testing Product
Table 38. Roche Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Roche Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 40. Roche Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 41. Roche Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 42. Roche Recent Developments
Table 43. Illumina Corporation Information
Table 44. Illumina Description and Business Overview
Table 45. Illumina Laboratory-developed Testing Product
Table 46. Illumina Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Illumina Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 48. Illumina Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 49. Illumina Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 50. Illumina Recent Developments
Table 51. Qiagen Corporation Information
Table 52. Qiagen Description and Business Overview
Table 53. Qiagen Laboratory-developed Testing Product
Table 54. Qiagen Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Qiagen Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 56. Qiagen Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 57. Qiagen Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 58. Qiagen Recent Developments
Table 59. Eurofins Corporation Information
Table 60. Eurofins Description and Business Overview
Table 61. Eurofins Laboratory-developed Testing Product
Table 62. Eurofins Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Eurofins Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 64. Eurofins Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 65. Eurofins Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 66. Eurofins Recent Developments
Table 67. Guardant Health Corporation Information
Table 68. Guardant Health Description and Business Overview
Table 69. Guardant Health Laboratory-developed Testing Product
Table 70. Guardant Health Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Guardant Health Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 72. Guardant Health Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 73. Guardant Health Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 74. Guardant Health Recent Developments
Table 75. Biotheranostics Corporation Information
Table 76. Biotheranostics Description and Business Overview
Table 77. Biotheranostics Laboratory-developed Testing Product
Table 78. Biotheranostics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Biotheranostics Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 80. Biotheranostics Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 81. Biotheranostics Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 82. Biotheranostics Recent Developments
Table 83. Adaptive Biotechnologies Corporation Information
Table 84. Adaptive Biotechnologies Description and Business Overview
Table 85. Adaptive Biotechnologies Laboratory-developed Testing Product
Table 86. Adaptive Biotechnologies Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Adaptive Biotechnologies Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 88. Adaptive Biotechnologies Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 89. Adaptive Biotechnologies Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 90. Adaptive Biotechnologies Recent Developments
Table 91. Rosetta Genomics Corporation Information
Table 92. Rosetta Genomics Description and Business Overview
Table 93. Rosetta Genomics Laboratory-developed Testing Product
Table 94. Rosetta Genomics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Rosetta Genomics Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 96. Rosetta Genomics Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 97. Rosetta Genomics Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 98. Rosetta Genomics Recent Developments
Table 99. Biodesix Corporation Information
Table 100. Biodesix Description and Business Overview
Table 101. Biodesix Laboratory-developed Testing Product
Table 102. Biodesix Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Biodesix Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 104. Biodesix Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 105. Biodesix Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 106. Biodesix Recent Developments
Table 107. Helix Corporation Information
Table 108. Helix Description and Business Overview
Table 109. Helix Laboratory-developed Testing Product
Table 110. Helix Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Helix Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 112. Helix Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 113. Helix Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 114. Helix Recent Developments
Table 115. North America Laboratory-developed Testing Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Laboratory-developed Testing Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Laboratory-developed Testing Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Laboratory-developed Testing Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Laboratory-developed Testing Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Laboratory-developed Testing Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Laboratory-developed Testing Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Laboratory-developed Testing Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Laboratory-developed Testing Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Laboratory-developed Testing Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 135. Laboratory-developed Testing Key Raw Materials, Industry Status and Trend
Table 136. Laboratory-developed Testing Key Raw Materials and Upstream Suppliers
Table 137. Laboratory-developed Testing Clients Status and Trend
Table 138. Laboratory-developed Testing Typical Clients
Table 139. Laboratory-developed Testing Distributors
Table 140. Laboratory-developed Testing Market Trends
Table 141. Laboratory-developed Testing Market Drivers
Table 142. Laboratory-developed Testing Market Challenges
Table 143. Laboratory-developed Testing Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Laboratory-developed Testing Product Picture
Figure 2. Global Laboratory-developed Testing Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Laboratory-developed Testing Revenue Market Share by Type in 2024 & 2031
Figure 4. Commercial Service Product Picture
Figure 5. R&D Product Picture
Figure 6. Global Laboratory-developed Testing Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Laboratory-developed Testing Revenue Market Share by Application in 2024 & 2031
Figure 8. Genetic Testing
Figure 9. Oncology
Figure 10. Infectious Disease
Figure 11. Others
Figure 12. Laboratory-developed Testing Report Years Considered
Figure 13. Global Laboratory-developed Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Laboratory-developed Testing Market Size (2020-2031) & (US$ Million)
Figure 15. Global Laboratory-developed Testing Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Laboratory-developed Testing Revenue Market Share by Region (2020-2031)
Figure 17. Global Laboratory-developed Testing Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Laboratory-developed Testing Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Commercial Service of Laboratory-developed Testing Revenue Market Share by Application, 2024 VS 2031
Figure 20. R&D of Laboratory-developed Testing Revenue Market Share by Application, 2024 VS 2031
Figure 21. Laboratory-developed Testing Revenue Share by Company (2024)
Figure 22. Laboratory-developed Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Commercial Service Revenue Proportion by Company in 2024
Figure 24. R&D Revenue Proportion by Company in 2024
Figure 25. North America Laboratory-developed Testing Revenue 2020-2031 (US$ Million)
Figure 26. North America Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 27. North America Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Laboratory-developed Testing Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 32. Europe Laboratory-developed Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Laboratory-developed Testing Revenue Market Share by Country (2020-2031)
Figure 34. Europe Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 35. Europe Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Laboratory-developed Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Laboratory-developed Testing Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Laboratory-developed Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 44. Laboratory-developed Testing Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Laboratory-developed Testing Raw Materials by Region in 2024
Figure 46. Laboratory-developed Testing Distribution Channels
Figure 47. Global Laboratory-developed Testing Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Laboratory-developed Testing Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Laboratory-developed Testing Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Laboratory-developed Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Laboratory-developed Testing Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Laboratory-developed Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Laboratory-developed Testing Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Laboratory-developed Testing Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Laboratory-developed Testing Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Laboratory-developed Testing Revenue by Company (2020-2025) & (US$ Million)
Table 11. Laboratory-developed Testing Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Laboratory-developed Testing Players by Revenue (US$ Million) in 2024
Table 13. Global Laboratory-developed Testing Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Laboratory-developed Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Laboratory-developed Testing as of 2024)
Table 15. Global Laboratory-developed Testing Companies Headquarters
Table 16. Date of International Companies Enter into Laboratory-developed Testing Market
Table 17. Global Laboratory-developed Testing Companies Product & Service
Table 18. Global Laboratory-developed Testing Mergers & Acquisitions, Expansion Plans
Table 19. Adaptive Biotechnologies Corporation Corporation Information
Table 20. Adaptive Biotechnologies Corporation Description and Business Overview
Table 21. Adaptive Biotechnologies Corporation Laboratory-developed Testing Product
Table 22. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Adaptive Biotechnologies Corporation Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 24. Adaptive Biotechnologies Corporation Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 25. Adaptive Biotechnologies Corporation Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 26. Adaptive Biotechnologies Corporation Recent Developments
Table 27. Quest Diagnostics Corporation Information
Table 28. Quest Diagnostics Description and Business Overview
Table 29. Quest Diagnostics Laboratory-developed Testing Product
Table 30. Quest Diagnostics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Quest Diagnostics Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 32. Quest Diagnostics Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 33. Quest Diagnostics Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 34. Quest Diagnostics Recent Developments
Table 35. Roche Corporation Information
Table 36. Roche Description and Business Overview
Table 37. Roche Laboratory-developed Testing Product
Table 38. Roche Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Roche Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 40. Roche Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 41. Roche Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 42. Roche Recent Developments
Table 43. Illumina Corporation Information
Table 44. Illumina Description and Business Overview
Table 45. Illumina Laboratory-developed Testing Product
Table 46. Illumina Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Illumina Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 48. Illumina Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 49. Illumina Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 50. Illumina Recent Developments
Table 51. Qiagen Corporation Information
Table 52. Qiagen Description and Business Overview
Table 53. Qiagen Laboratory-developed Testing Product
Table 54. Qiagen Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Qiagen Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 56. Qiagen Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 57. Qiagen Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 58. Qiagen Recent Developments
Table 59. Eurofins Corporation Information
Table 60. Eurofins Description and Business Overview
Table 61. Eurofins Laboratory-developed Testing Product
Table 62. Eurofins Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Eurofins Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 64. Eurofins Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 65. Eurofins Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 66. Eurofins Recent Developments
Table 67. Guardant Health Corporation Information
Table 68. Guardant Health Description and Business Overview
Table 69. Guardant Health Laboratory-developed Testing Product
Table 70. Guardant Health Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Guardant Health Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 72. Guardant Health Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 73. Guardant Health Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 74. Guardant Health Recent Developments
Table 75. Biotheranostics Corporation Information
Table 76. Biotheranostics Description and Business Overview
Table 77. Biotheranostics Laboratory-developed Testing Product
Table 78. Biotheranostics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Biotheranostics Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 80. Biotheranostics Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 81. Biotheranostics Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 82. Biotheranostics Recent Developments
Table 83. Adaptive Biotechnologies Corporation Information
Table 84. Adaptive Biotechnologies Description and Business Overview
Table 85. Adaptive Biotechnologies Laboratory-developed Testing Product
Table 86. Adaptive Biotechnologies Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Adaptive Biotechnologies Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 88. Adaptive Biotechnologies Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 89. Adaptive Biotechnologies Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 90. Adaptive Biotechnologies Recent Developments
Table 91. Rosetta Genomics Corporation Information
Table 92. Rosetta Genomics Description and Business Overview
Table 93. Rosetta Genomics Laboratory-developed Testing Product
Table 94. Rosetta Genomics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Rosetta Genomics Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 96. Rosetta Genomics Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 97. Rosetta Genomics Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 98. Rosetta Genomics Recent Developments
Table 99. Biodesix Corporation Information
Table 100. Biodesix Description and Business Overview
Table 101. Biodesix Laboratory-developed Testing Product
Table 102. Biodesix Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Biodesix Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 104. Biodesix Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 105. Biodesix Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 106. Biodesix Recent Developments
Table 107. Helix Corporation Information
Table 108. Helix Description and Business Overview
Table 109. Helix Laboratory-developed Testing Product
Table 110. Helix Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Helix Revenue Proportion of Laboratory-developed Testing by Product in 2024
Table 112. Helix Revenue Proportion of Laboratory-developed Testing by Application in 2024
Table 113. Helix Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2024
Table 114. Helix Recent Developments
Table 115. North America Laboratory-developed Testing Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Laboratory-developed Testing Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Laboratory-developed Testing Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Laboratory-developed Testing Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Laboratory-developed Testing Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Laboratory-developed Testing Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Laboratory-developed Testing Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Laboratory-developed Testing Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Laboratory-developed Testing Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Laboratory-developed Testing Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Laboratory-developed Testing Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Laboratory-developed Testing Revenue by Application (2020-2025) & (US$ Million)
Table 135. Laboratory-developed Testing Key Raw Materials, Industry Status and Trend
Table 136. Laboratory-developed Testing Key Raw Materials and Upstream Suppliers
Table 137. Laboratory-developed Testing Clients Status and Trend
Table 138. Laboratory-developed Testing Typical Clients
Table 139. Laboratory-developed Testing Distributors
Table 140. Laboratory-developed Testing Market Trends
Table 141. Laboratory-developed Testing Market Drivers
Table 142. Laboratory-developed Testing Market Challenges
Table 143. Laboratory-developed Testing Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Laboratory-developed Testing Product Picture
Figure 2. Global Laboratory-developed Testing Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Laboratory-developed Testing Revenue Market Share by Type in 2024 & 2031
Figure 4. Commercial Service Product Picture
Figure 5. R&D Product Picture
Figure 6. Global Laboratory-developed Testing Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Laboratory-developed Testing Revenue Market Share by Application in 2024 & 2031
Figure 8. Genetic Testing
Figure 9. Oncology
Figure 10. Infectious Disease
Figure 11. Others
Figure 12. Laboratory-developed Testing Report Years Considered
Figure 13. Global Laboratory-developed Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Laboratory-developed Testing Market Size (2020-2031) & (US$ Million)
Figure 15. Global Laboratory-developed Testing Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Laboratory-developed Testing Revenue Market Share by Region (2020-2031)
Figure 17. Global Laboratory-developed Testing Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Laboratory-developed Testing Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Commercial Service of Laboratory-developed Testing Revenue Market Share by Application, 2024 VS 2031
Figure 20. R&D of Laboratory-developed Testing Revenue Market Share by Application, 2024 VS 2031
Figure 21. Laboratory-developed Testing Revenue Share by Company (2024)
Figure 22. Laboratory-developed Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Commercial Service Revenue Proportion by Company in 2024
Figure 24. R&D Revenue Proportion by Company in 2024
Figure 25. North America Laboratory-developed Testing Revenue 2020-2031 (US$ Million)
Figure 26. North America Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 27. North America Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Laboratory-developed Testing Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 32. Europe Laboratory-developed Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Laboratory-developed Testing Revenue Market Share by Country (2020-2031)
Figure 34. Europe Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 35. Europe Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Laboratory-developed Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Laboratory-developed Testing Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Laboratory-developed Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Application (2020-2025)
Figure 44. Laboratory-developed Testing Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Laboratory-developed Testing Raw Materials by Region in 2024
Figure 46. Laboratory-developed Testing Distribution Channels
Figure 47. Global Laboratory-developed Testing Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Laboratory-developed Testing Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232